No abstract

No abstract

Aims: This study aimed at evaluating the effect of Algo-Bio® use on Escherichia coli resistance strains isolated from piglets intestinal flora. Study Design: Bacteriological study. Place and Duration of Study: Laboratory of the National Reference Center for antibiotics at Institute Pasteur Côte d’Ivoire, between March 2018 and June 2018. Methodology: A breeding of three batches of two piglets was carried out, then treatments with tetracycline and Algo-Bio® were administered to them. Enterobacteria was isolated on Mac Conkey medium added up with tetracycline and resistance rates were determined. Escherichia coli resistant strains have been identified and antibiotic susceptibility test was performed using disk diffusion method on Müller-Hinton agar. Results: Enterobacteria resistance rates increased ranging from 18.4% (D0) to 81.5% (D4) to tetracycline-treated piglets and respectively from 25.7% (D0) to 29% (D4) and from 22.3% (D0) to 24.5% (D4), in control piglets and those treated with Algo-Bio®. Antibiotic susceptibility test of Escherichia coli strains isolated from piglets treated with tetracycline showed high resistance to ceftazidime (83.3%), amoxicillin (76.9%) and tetracycline (92.3%) with 39.4% strains producing ESBL, 23.7% producing PHL and 5.2% of producing CHP on D4. Escherichia coli strains isolated from control piglets and Algo-Bio® treated piglets revealed a decrease of ESBL respectively from 17.6% (D0) to 13.7% (D4) and from 12.5% ​​(D0) to 6.4% (D4). Conclusion: The study showed that the use of Algo-Bio® does not induce an evolution of antimicrobial resistance in Microbiota strains and consequently this dietary supplement can be used as a good alternative to antibiotics.

Objective: The aim of this study was to evaluate the level of selection of amoxicillin-resistant Enterobacteriaceae in the digestive microbiota of piglets during oral and intramuscular administration of amoxicillin. Methodology and Results: Enumeration of Enterobacteriaceae was carried out on MacConkey agar with and without amoxicillin. E. coli isolates were identified and subjected to antimicrobial susceptibility test. The percentages of amoxicillin-resistant Enterobacteriaceae before treatment were between 10-13% for the three groups of piglets. After starting treatment of amoxicillin, from day 1 to day 4, the percentages of resistant Enterobacteriaceae were between 54 to 81% for the intramuscular treated groups and 58 to 87% for those treated orally. In the control group, percentage was 11%. During days of treatments, the percentage of amoxicillin-resistant E. coli strains to the associated antibiotics evolved during the treatments. In the control piglets, the percentages of E. coli resistant antibiotics did not increase. Conclusion and application of findings: Administration of oral amoxicillin resulted in a greater selection of resistant enterobacteria in the digestive microbiota of piglets than those induced by the intramuscular route. Escherichia coli, an important strain in animal and human pathology, was the target of detection in this selection of these resistant enterobacteria. They constitute a public health risk due to the transfer of resistance genes from pathogenic bacteria of porcine origin to the human digestive flora via the food chain. The results obtained from this study are part of a bacterial resistance monitoring policy that will prevent pig farmers from Côte d'Ivoire, the majority user of these antibiotics.

No abstract